Contents

20 Tuberculosis

References

  1. Ministry of Health. 2010. Guidelines for Tuberculosis Control in New Zealand 2010. URL: www.health.govt.nz/publication/guidelines-tuberculosis-control-new-zealand-2010
  2. Horsburgh CR Jr. 2004. Priorities for the treatment of latent tuberculosis infection in the United States. New England Journal of Medicine 350(20): 2060–7.
  3. Marais BJ, Gie RP, Schaaf HS, et al. 2004. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. International Journal of Tuberculosis and Lung Disease 8(4): 392–402.
  4. World Health Organization. 2013. Global Tuberculosis Report 2013. URL: http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf (accessed 1 November 2013).
  5. Lim E, Heffernan H. 2013. Tuberculosis in New Zealand: Annual report 2012. URL: https://surv.esr.cri.nz/PDF_surveillance/AnnTBReports/TBAnnualReport2012.pdf (accessed 1 November 2013).
  6. Connelly Smith K, Orme IM, Starke JR. 2013. Tuberculosis vaccines. In: Plotkin SA, Orenstein WA, Offit PA (eds). Vaccines (6th edition): Elsevier Saunders.
  7. Anderson EJ, Webb EL, Mawa PA, et al. 2012. The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda. Vaccine 30(12): 2083–9.
  8. Aaby P, Benn C, Nielsen J, et al. 2012. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2(3). DOI: 10.1136/bmjopen-2011-000707 (accessed 16 January 2013).
  9. Lalor MK, Floyd S, Gorak-Stolinska P, et al. 2011. BCG vaccination: a role for vitamin D? PLOS ONE 6(1). DOI: 10.1371/journal.pone.0016709 (accessed 16 January 2013).
  10. Mazzola TN, da Silva MTN, Abramczuk BM, et al. 2011. Impaired Bacillus Calmette-Guerin cellular immune response in HIV-exposed, uninfected infants. Aids 25(17): 2079–87.
  11. World Health Organization. BCG Vaccine. URL: www.who.int/biologicals/areas/vaccines/bcg/en/ (accessed 15 January 2013).
  12. Zwerling A, Behr MA, Verma A, et al. 2011. BCG world atlas: a database of Global BCG vaccination policies and practices. PLOS Medicine 8(3). DOI: 10.1371/journal.pmed.1001012 (accessed 25 November 2013).
  13. World Health Organization. 2004. BCG vaccine: WHO position paper. Weekly Epidemiological Record 79(4): 27–38.
  14. Altes HK, Dijkstra F, Lugnèr A, et al. 2009. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment. Epidemiology 20(4): 562–8.
  15. Ottenhoff TH, Kaufmann SH. 2012. Vaccines against tuberculosis: where are we and where do we need to go? PLOS Pathogens 8(5). DOI: 0.1371/journal.ppat.1002607 (accessed 15 January 2013).
  16. Ministry of Health. 2012. National Guidelines for Vaccine Storage and Distribution. URL: www.health.govt.nz/publication/national-guidelines-vaccine-storage-and-distribution-2012
  17. Ministry of Health. 1996. Technical Guidelines for Tuberculin Testing and BCG Vaccination 1996. URL: www.moh.govt.nz/notebook/nbbooks.nsf/0/940C7A59732C76154C2565D700187D7B/$file/Technical Guidelines TB and BCG 1996.pdf
  18. World Health Organization. WHO Vaccine-preventable Diseases: Monitoring system: 2013 global summary. URL: http://apps.who.int/immunization_monitoring/globalsummary/schedules (accessed 21 August 2013).
  19. Sedaghatian MR, Hashem F, Moshaddeque Hossain M. 1998. Bacille Calmette Guérin vaccination in pre-term infants. International Journal of Tuberculosis and Lung Disease 2(8): 679–82.
  20. Thayyil-Sudhan S, Kumar A, Singh M, et al. 1999. Safety and effectiveness of BCG vaccination in preterm babies. Archives of Disease in Childhood: Fetal and Neonatal Edition 81(1): F64–6.
  21. Sedaghatian MR, Kardouni K. 1993. Tuberculin response in preterm infants after BCG vaccination at birth. Archives of Disease in Childhood 69(3 Spec no): 309–11.
  22. Ferreira AA, Bunn-Moreno MM, Sant’Anna CC, et al. 1996. BCG vaccination in low birth weight newborns: analysis of lymphocyte proliferation, IL-2 generation and intradermal reaction to PPD. Tubercle and Lung Disease 77(5): 476–81.
  23. Cheent K, Nolan J, Shariq S, et al. 2010. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn’s disease. Journal of Crohn’s and Colitis 4(5): 603–5.
  24. Caglayan S, Yegin O, Kayean K, et al. 1987. Is medical therapy effective for regional lymphadenitis following BCG vaccination? American Journal of Diseases in Children 141(11): 1213–14.
  25. Centers for Disease Control and Prevention. 2010. Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection – United States, 2010. Morbidity and Mortality Weekly Report: Recommendations and Reports 59(RR05). URL: www.cdc.gov/mmwr/preview/mmwrhtml/rr5905a1.htm (accessed 1 November 2013).
  26. Ministry of Health. 2012. Communicable Disease Control Manual 2012. URL: www.health.govt.nz/publication/communicable-disease-control-manual-2012